Company Filing History:
Years Active: 2025
Title: Han Dong: Innovator in Immune Response Modulation
Introduction
Han Dong is a prominent inventor based in Boston, MA. He has made significant contributions to the field of immunology, particularly in the modulation of immune responses. His innovative work has led to the development of a patent that addresses critical aspects of NK cell immunity.
Latest Patents
Han Dong holds a patent titled "Use of IRE1α-XBP1 signaling pathway biomarkers for modulating immune responses." This invention is based on the identification of an IRE1α-XBP1-cMyc axis in NK cell immunity. The patent provides compositions and methods for treating conditions that would benefit from modulating an immune response using agents that influence the IRE1α-XBP1 pathway or compositions comprising modified NK cells.
Career Highlights
Han Dong is affiliated with the Dana-Farber Cancer Institute Inc., where he continues to advance research in cancer and immunology. His work has been instrumental in understanding how immune responses can be effectively modulated to improve patient outcomes.
Collaborations
Han Dong collaborates with notable professionals in his field, including Laurie H. Glimcher, enhancing the impact of his research through shared expertise and knowledge.
Conclusion
Han Dong's innovative contributions to the modulation of immune responses highlight his role as a key inventor in the field of immunology. His patent and ongoing research at the Dana-Farber Cancer Institute Inc. demonstrate his commitment to advancing medical science and improving therapeutic strategies.